Drug therapy of prostatic cancer.

Abstract:

:While hormonal therapy has been the usual and appropriate treatment of advanced or metastatic prostatic cancer for the past 50 years, the recent development of new therapeutic agents as medical alternatives to orchidectomy has drastically altered the options and perspectives in the treatment of this disease. Estrogens had been the only commonly used drug therapy in the United States. Newer alternatives include androgen synthesis inhibitors, a class of agents termed antiandrogens, and gonadotrophin-releasing hormone (GnRH) [luteinising hormone-releasing hormone (LHRH)] analogues, either alone or in combination. As the result of basic scientific studies and prospective clinical trials which have examined the issue of risk versus benefit, several trends have emerged. In the United States, orchidectomy is waning as the primary treatment option for metastatic prostatic cancer, while estrogen use has declined drastically; GnRH analogues are being prescribed more frequently. Furthermore, combination therapy with GnRH analogues (or orchidectomy, to a lesser extent) and the antiandrogen flutamide is gaining wider acceptance as a primary treatment option. The rationale, advantages, and real or potential disadvantages of these various treatment options are discussed.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Huben RP,Perrapato SD

doi

10.2165/00002512-199101050-00003

subject

Has Abstract

pub_date

1991-09-01 00:00:00

pages

353-63

issue

5

eissn

1170-229X

issn

1179-1969

journal_volume

1

pub_type

杂志文章,评审
  • Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

    abstract::High fasting plasma homocysteine levels (> 12 to 15 mumol/L) are commonly encountered in clinical practice and are associated with increased risk of atherothrombotic disease. Treatment with folic acid (1 to 5 mg/day) is inexpensive and effective in normalising plasma homocysteine levels. High plasma homocysteine level...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200016040-00001

    authors: Stehouwer DA

    更新日期:2000-04-01 00:00:00

  • Advances in the pharmacological treatment of gastro-oesophageal cancer.

    abstract::Despite a sharp decline in the incidence of gastric cancer during the second half of the 20th century, this malignancy remains the second leading cause of cancer mortality in the world. The incidence and mortality rate of gastric cancer increase with age; at present, the median ages at diagnosis are 67 years for men a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11315740-000000000-00000

    authors: Wagner AD,Wedding U

    更新日期:2009-01-01 00:00:00

  • Managing Gout in the Patient with Renal Impairment.

    abstract::Hyperuricaemia is an independent risk factor for renal function decline. Evidence is emerging that urate-lowering therapy might be beneficial in subjects with renal impairment. We  review the association between renal impairment and gout, some of the related pathogenic processes and the possible impact of gout treatme...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-018-0517-7

    authors: Pascual E,Sivera F,Andrés M

    更新日期:2018-04-01 00:00:00

  • Quality measures for medication continuity in long-term care facilities, using a structured panel process.

    abstract:BACKGROUND:Patient transitions, such as transfers between acute and long-term care (LTC), aposare times when the likelihood of communication failure between healthcare providers is increased. Employing appropriate health quality indicators helps support improvement efforts. To date, few quality indicators that evaluate...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11599150-000000000-00000

    authors: Bell CM,Brener SS,Comrie R,Anderson GM,Bronskill SE

    更新日期:2012-04-01 00:00:00

  • Disease-modifying antirheumatic drugs. Potential effects in older patients.

    abstract::Disease-modifying antirheumatic drugs (DMARDs) are frequently used in rheumatoid arthritis. A number of physiological changes occur in the elderly which may modify the use of these medications. The most commonly used DMARDs are antimalarial drugs (particularly hydroxychloroquine), sulfasalazine and methotrexate. The p...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199507060-00003

    authors: Gardner G,Furst DE

    更新日期:1995-12-01 00:00:00

  • Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study.

    abstract:BACKGROUND:Older people often take multiple medications. It is a policy priority to facilitate older people to stay at home longer. Three-quarters of nursing home placements in the US are preceded by a hospitalization. OBJECTIVE:To investigate the association between polypharmacy and medication regimen complexity with...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0185-1

    authors: Wimmer BC,Dent E,Visvanathan R,Wiese MD,Johnell K,Chapman I,Bell JS

    更新日期:2014-08-01 00:00:00

  • New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly.

    abstract::NSAIDs are a widely used class of analgesic and anti-inflammatory drugs that act by inhibiting the cyclo-oxygenase (COX) enzyme. However, because of their nonspecificity of action, use of these agents as long-term therapy for chronic pain in diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA) is often d...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200724060-00001

    authors: Bansal SS,Joshi A,Bansal AK

    更新日期:2007-01-01 00:00:00

  • Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

    abstract::Etidronic acid is an orally and intravenously active bisphosphonate, which is believed to inhibit resorption of bone via a number of cellular mechanisms, including alteration of osteoclastic activity. In studies of patients with symptomatic Paget's disease, etidronic acid 5 to 20 mg/kg/day administered orally rapidly ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199405060-00006

    authors: Dunn CJ,Fitton A,Sorkin EM

    更新日期:1994-12-01 00:00:00

  • Diagnosis and treatment of patients with severe Alzheimer's disease.

    abstract::In contrast with the earlier stages and, in particular, the predementia stage, of Alzheimer's disease (AD), severe dementia is often neglected. However, the advanced stages of dementia are just as important as the earlier stages because of their frequency, their impact on the lives of patients and their caregivers, an...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/0002512-200926020-00005

    authors: Voisin T,Vellas B

    更新日期:2009-01-01 00:00:00

  • Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.

    abstract:BACKGROUND:The use of proton pump inhibitors (PPIs) in older adults is high, often inappropriate, and may cause harm. Deprescribing is defined as the reduction, withdrawal, or discontinuation of inappropriate medication. OBJECTIVE:We conducted a systematic review to determine the effectiveness of interventions to depr...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0442-1

    authors: Wilsdon TD,Hendrix I,Thynne TR,Mangoni AA

    更新日期:2017-04-01 00:00:00

  • Current recommendations for the prevention and treatment of influenza in the older population.

    abstract::Influenza is a major cause of morbidity and mortality in the elderly. Influenza vaccine is recommended for people aged 65 years and older and those in long term care. Currently only 30% of high risk persons are vaccinated. Vaccination generally stimulates an adequate immune response, is well tolerated and is to be enc...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101060-00003

    authors: Gross PA

    更新日期:1991-11-01 00:00:00

  • Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.

    abstract::Felodipine is a dihydropyridine calcium antagonist which may be administered once daily in an extended release (ER) formulation. As monotherapy in older patients with mild to moderate essential hypertension, felodipine ER once daily provides effective control of blood pressure (BP). The drug has also been effective, e...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199202050-00002

    authors: Faulds D,Sorkin EM

    更新日期:1992-09-01 00:00:00

  • Hyperparathyroidism in the elderly patient.

    abstract::Primary hyperparathyroidism is a common metabolic bone disease and currently presents a significant management dilemma. Most of the patients have few relevant symptoms and surgical parathyroidectomy offers the prospect of cure with freedom from the risk of long-term complications or the need for a follow-up. However, ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421150-00004

    authors: Sims R,Ubhi C,Hosking D

    更新日期:2004-01-01 00:00:00

  • The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.

    abstract::Rheumatoid arthritis (RA) and osteoarthritis are chronic diseases that result in cartilage degradation and loss of joint function. Currently available drugs are predominantly directed towards the control of pain and/or the inflammation associated with joint synovitis but they do little to reduce joint destruction. In ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118020-00002

    authors: Elliott S,Cawston T

    更新日期:2001-01-01 00:00:00

  • Extended-release oxybutynin.

    abstract::Extended-release oxybutynin (Ditropan XL) uses an osmotic system (OROS) to deliver a controlled amount of oxybutynin chloride into the gastrointestinal tract over a 24-hour period when taken once daily. Oxybutynin binds to M3 muscarinic receptors on the detrusor muscle of the bladder, preventing acetylcholinergic acti...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200016020-00008

    authors: Comer AM,Goa KL

    更新日期:2000-02-01 00:00:00

  • Clinically significant drug interactions with antidepressants in the elderly.

    abstract::Pharmacological treatment of depression in old age is associated with an increased risk of adverse pharmacokinetic and pharmacodynamic drug interactions. Elderly patients may have multiple disease states and, therefore, may require a variety of other drugs. In addition to polypharmacy, other factors such as age-relate...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219040-00004

    authors: Spina E,Scordo MG

    更新日期:2002-01-01 00:00:00

  • Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.

    abstract:BACKGROUND:In the presence of multimorbidity and limited life expectancy (LLE), the need for continued use of preventive medicines becomes uncertain as they may neither improve health nor confer continued health benefits. OBJECTIVE:Our objective was to systematically review the literature to examine the discontinuatio...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0487-1

    authors: Narayan SW,Nishtala PS

    更新日期:2017-10-01 00:00:00

  • Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.

    abstract:BACKGROUND:Patients hospitalised with severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2; coronavirus 2019 disease (COVID-19)] infection are frequently older with co-morbidities and receiving polypharmacy, all of which are known risk factors for drug-drug interactions (DDIs). The pharmacological burden may be ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-020-00812-8

    authors: Cattaneo D,Pasina L,Maggioni AP,Giacomelli A,Oreni L,Covizzi A,Bradanini L,Schiuma M,Antinori S,Ridolfo A,Gervasoni C

    更新日期:2020-12-01 00:00:00

  • Influenza vaccination in the elderly: impact on hospitalisation and mortality.

    abstract::Influenza causes substantial morbidity across the age spectrum. However, the elderly are especially vulnerable to the serious complications of influenza that might result in hospitalisation or death, and high rates of influenza-associated excess hospitalisation or death that exceed by several-fold the rates seen among...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析,评审

    doi:10.2165/00002512-200522060-00004

    authors: Nichol KL

    更新日期:2005-01-01 00:00:00

  • Transdermal treatment options for neurological disorders: impact on the elderly.

    abstract::As people grow old, their need for medications increases dramatically because of the higher incidence of chronic pain, diabetes mellitus, cardiovascular and neurological diseases in the elderly population. Furthermore, the elderly require special consideration with respect to drug delivery, drug interactions and adher...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200623050-00001

    authors: Priano L,Gasco MR,Mauro A

    更新日期:2006-01-01 00:00:00

  • Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study.

    abstract:BACKGROUND:The number of elderly patients with oesophageal cancer is expected to increase with the aging of the population and the rapidly increasing incidence of adenocarcinoma. Surgical resection is standard treatment for patients with localized disease considered fit for operation. However, elderly patients with oes...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200926030-00006

    authors: Servagi-Vernat S,Bosset M,Crehange G,Buffet-Miny J,Puyraveau M,Maingon P,Mercier M,Bosset JF

    更新日期:2009-01-01 00:00:00

  • Trends in the Dispensing and Costs of Glucose-Lowering Medications Among Older Australians: Findings from National Claims Data.

    abstract:BACKGROUND:Temporal changes in the dispensing of glucose-lowering drugs (GLD) and their associated costs among elderly populations is unclear. This information is especially relevant to countries in which medications are partly or fully government subsidized. OBJECTIVE:Our objective was to estimate the trends in preva...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-020-00759-w

    authors: Chin KL,Hidayat FM,Ofori-Asenso R,Ilomäki J,Bell JS,Zoungas S,Liew D

    更新日期:2020-05-01 00:00:00

  • Scabies outbreaks in nursing homes for the elderly: recognition, treatment options and control of reinfestation.

    abstract::The scabies mite is an ectoparasite able to infest humans. Its clinical presentation is typical, although in immunocompromised, mentally retarded and elderly patients the clinical presentation may be altered. Diagnosis may therefore be difficult in such patient groups, who often reside in nursing homes. Because delay ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200825040-00003

    authors: Tjioe M,Vissers WH

    更新日期:2008-01-01 00:00:00

  • Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators.

    abstract:BACKGROUND:Medication for elderly patients is often complex and problematic. Several criteria for classifying inappropriate prescribing exist. In 2010, the Swedish National Board of Health and Welfare published the document "Indicators of appropriate drug therapy in the elderly" as a guideline for improving prescribing...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0165-5

    authors: Hovstadius B,Petersson G,Hellström L,Ericson L

    更新日期:2014-05-01 00:00:00

  • NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.

    abstract:BACKGROUND:Several studies have suggested that NSAID use may modify the risk of developing Parkinson's disease (PD). OBJECTIVE:Our aim was to conduct a meta-analysis of observational studies evaluating NSAID use and the risk of PD. METHODS:We systematically searched MEDLINE (1966-November 2008), EMBASE (1980-November...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析,评审

    doi:10.2165/11316780-000000000-00000

    authors: Samii A,Etminan M,Wiens MO,Jafari S

    更新日期:2009-01-01 00:00:00

  • Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

    abstract::Cyproterone (cyproterone acetate) is a steroidal antiandrogenic agent that inhibits the action of adrenal and testicular androgens on prostatic cells. Additionally, its progestogenic activity causes a centrally mediated reduction in testicular secretion of androgens. Studies have demonstrated the effectiveness of cypr...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199405010-00006

    authors: Barradell LB,Faulds D

    更新日期:1994-07-01 00:00:00

  • Rational approach to the antibiotic treatment of pneumonia in the elderly.

    abstract::The incidence of pneumonia is highest among the aged compared with other adult populations, and causes significant morbidity and mortality among this group. Most episodes of pneumonia are caused by aspiration of oropharyngeal flora into the lungs and failure of lung defence mechanisms to eliminate the aspirated bacter...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199404010-00003

    authors: Mylotte JM,Ksiazek S,Bentley DW

    更新日期:1994-01-01 00:00:00

  • Opioids for the treatment of chronic non-cancer pain in older people.

    abstract::Chronic pain occurs in 45-85% of the geriatric population and the need to treat chronic pain is growing substantially. Unfortunately, treatment for chronic pain is not always correctly targeted, which leads to a reduced quality of life, with decreased socialization, depression, sleep disturbances, cognitive impairment...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11534670-000000000-00000

    authors: Gianni W,Ceci M,Bustacchini S,Corsonello A,Abbatecola AM,Brancati AM,Assisi A,Scuteri A,Cipriani L,Lattanzio F

    更新日期:2009-12-01 00:00:00

  • Intermittent claudication in older patients. Practical treatment guidelines.

    abstract::The prevalence of intermittent claudication (IC) increases with age; when questioned, older patients consider increased difficulty in walking to be a normal consequence of aging. Although the prognosis for the involved limb with IC is relatively good, IC is an important clinical predictor of increased cardiovascular m...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199914040-00002

    authors: Boccalon H

    更新日期:1999-04-01 00:00:00

  • Optimal management of gout in older patients.

    abstract::Gout in older patients tends to be sub-acute to chronic, often tophaceous, polyarticular, erosive, symmetrical, and causes persistent, recurrent and chronic arthritis. Clinically, it may closely mimic rheumatoid arthritis; thus, a correct diagnosis requires a high index of clinical suspicion and the identification of ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199404020-00005

    authors: Gonzalez EB,Miller SB,Agudelo CA

    更新日期:1994-02-01 00:00:00